CAPR – capricor therapeutics, inc. (US:NASDAQ)

News

Capricor Therapeutics (NASDAQ:CAPR) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Capricor Therapeutics (NASDAQ:CAPR) was downgraded by analysts at Wall S
Capricor Therapeutics: A High Risk/High Reward Name [Seeking Alpha]
Here's Why This Biotechnology Skyrocketed by 439% in December [Yahoo! Finance]
Capricor Therapeutics (NASDAQ:CAPR) was upgraded by analysts at Wall Str
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com